Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-pantoprazole in Non-Erosive Reflux Disease
NCT02274961Phase 3Unknown
- Sponsor
- Ahn-Gook Pharmaceutical Co., Ltd.
- Start
- Oct 2014
- Primary completion
- Jul 2015
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in non-erosive reflux disease (NERD) comparing S-pantoprazole 10mg with Placebo (2 arms). Primary endpoint: Complete resolution of heartburn (HB) per Questionnaire at 4 weeks. Status: unknown.
02
Drugs
s-pantoprazole
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT02274961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02274961.